Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Kramar

Showing results (31-40 of 112) with videos related to

Pageof 12
Sort By:
British Journal of Cancer|November 1, 1992
Competing risks determining event-free survival in early breast cancerR Arriagada, L E Rutqvist, A Kramar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1996
High-dose chemotherapy in germ-cell tumorsJ P Droz, S Culine, P Biron, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1992
Competing events determining relapse-free survival in limited small-cell lung carcinoma. The French Cancer Centers' Lung GroupR Arriagada, A Kramar, T Le Chevalier, et al.
Cancer|January 1, 1981
Cure rate estimation and long-term prognosis of uterine cervix carcinomaM H Pejovic, J P Wolff, A Kramar, et al.
Disease Markers|May 31, 2001
Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancerM Ychou, J Duffour, A Kramar, et al.
Journal of the National Cancer Institute|September 1, 1986
Consumption of dairy produce and alcohol in a case-control study of breast cancerM G Lê, L H Moulton, C Hill, et al.
Revue D'Epidemiologie Et De Sante Publique|October 16, 1999
[Generalized ROC criteria in the evaluation of several tumor markers]A Kramar, D Faraggi, M Ychou, et al.
The International Journal of Biological Markers|October 9, 2007
Peritoneal fluid cytokines and the differential diagnosis of benign and malignant ovarian tumors and residual/recurrent disease examinationM Chechlinska, J Kaminska, J Markowska, et al.
Lung Cancer (Amsterdam, Netherlands)|September 21, 2000
Pro-gastrin-releasing peptide, neuron specific enolase and chromogranin A as serum markers of small cell lung cancerP J Lamy, J Grenier, A Kramar, et al.
Methods of Information in Medicine|October 5, 2006
Measuring agreement for ordered ratings in 3 x 3 tablesD Neveu, P Aubas, F Seguret, et al.
Pageof 12

Showing results (31-40 of 112) with videos related to

Sort By:
Pageof 12
British Journal of Cancer|November 1, 1992
Competing risks determining event-free survival in early breast cancerR Arriagada, L E Rutqvist, A Kramar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1996
High-dose chemotherapy in germ-cell tumorsJ P Droz, S Culine, P Biron, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1992
Competing events determining relapse-free survival in limited small-cell lung carcinoma. The French Cancer Centers' Lung GroupR Arriagada, A Kramar, T Le Chevalier, et al.
Cancer|January 1, 1981
Cure rate estimation and long-term prognosis of uterine cervix carcinomaM H Pejovic, J P Wolff, A Kramar, et al.
Disease Markers|May 31, 2001
Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancerM Ychou, J Duffour, A Kramar, et al.
Journal of the National Cancer Institute|September 1, 1986
Consumption of dairy produce and alcohol in a case-control study of breast cancerM G Lê, L H Moulton, C Hill, et al.
Revue D'Epidemiologie Et De Sante Publique|October 16, 1999
[Generalized ROC criteria in the evaluation of several tumor markers]A Kramar, D Faraggi, M Ychou, et al.
The International Journal of Biological Markers|October 9, 2007
Peritoneal fluid cytokines and the differential diagnosis of benign and malignant ovarian tumors and residual/recurrent disease examinationM Chechlinska, J Kaminska, J Markowska, et al.
Lung Cancer (Amsterdam, Netherlands)|September 21, 2000
Pro-gastrin-releasing peptide, neuron specific enolase and chromogranin A as serum markers of small cell lung cancerP J Lamy, J Grenier, A Kramar, et al.
Methods of Information in Medicine|October 5, 2006
Measuring agreement for ordered ratings in 3 x 3 tablesD Neveu, P Aubas, F Seguret, et al.
Pageof 12